Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2003 Nov;62 Suppl 2(Suppl 2):ii73-8.
doi: 10.1136/ard.62.suppl_2.ii73.

Cartilage morphogenetic proteins: role in joint development, homoeostasis, and regeneration

Affiliations
Review

Cartilage morphogenetic proteins: role in joint development, homoeostasis, and regeneration

A H Reddi. Ann Rheum Dis. 2003 Nov.

Abstract

Background: Articular cartilage homoeostasis is critical for joint function. The steady state homoeostasis of articular cartilage is a balance between anabolic morphogens such as cartilage derived morphogenetic proteins (CDMPs) and bone morphogenetic proteins (BMPs) of the BMP family and catabolic cytokines such as interleukin (IL)1, IL17, and tumour necrosis factor alpha. Although bone and articular cartilage are adjacent tissues, there is a profound difference in their regeneration potential. Bone has the highest potential for regeneration. On the other hand, articular cartilage is recalcitrant to repair.

Objective: To examine the hypothesis that the feeble innate regeneration ability of cartilage is due to the preponderance of catabolic cytokines such as IL1 and IL17.

Results: During a systematic investigation of CDMPs and cytokines IL17B (chondroleukin) was found in bovine articular cartilage.

Discussion and conclusions: BMP-7 and IL17B are present in articular cartilage and synthesised in chondrocytes as shown by northern blots and real-time reverse transcription-polymerase chain reaction. The coexistence of anabolic morphogens and catabolic cytokines in articular cartilage has important implications for cartilage homoeostasis and regeneration. The networks of signalling systems of morphogens and cytokines determine the net capacity for regenerative morphogenesis of articular cartilage. Finally, the feeble innate capacity for articular cartilage may be improved by targeted therapy by soluble receptors to block catabolic cytokines.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Articular cartilage homoeostasis in the joint. Anabolic morphogens such as CDMPs and BMPs initiate cartilage morphogenesis and maintain the extracellular matrix components such as collagens II, IX, and XI and aggrecan. On the other hand, catabolic cytokines such as the interleukin (IL)1, IL17 family, and tumour necrosis factor α (TNFα) degrade the cartilage matrix by stimulating matrix turnover enzymes and inhibiting the tissue inhibitors of metalloproteinases. The actions of BMPs are antagonised by BMP antagonists, noggin, chordin, and DAN. The structural integrity of the extracellular matrix is vital to cartilage homoeostasis. Alterations in articular cartilage homoeostasis may lead to progressive loss of articular function in arthritis. Advances in targeted therapeutic agents to block aggrecanases and catabolic cytokines may lead to improved cartilage homoeostasis.

References

    1. Science. 1998 May 29;280(5368):1455-7 - PubMed
    1. J Cell Biol. 1999 Jan 11;144(1):161-73 - PubMed
    1. Cell. 1995 Mar 10;80(5):739-46 - PubMed
    1. Ann Med. 1994 Apr;26(2):107-14 - PubMed
    1. Nat Genet. 1994 Oct;8(2):129-35 - PubMed

Substances